Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (241-250 of 491) with videos related to

Pageof 50
Sort By:
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Wiener Klinische Wochenschrift|July 27, 2017
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patientsDavid Chromy, Philipp Schwabl, Theresa Bucsics, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2026
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular CarcinomaTobias Meischl, Moritz Steurer, Lorenz Balcar, et al.
Digestive Diseases and Sciences|June 19, 2019
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal HypertensionGeorg Semmler, Judith Stift, Bernhard Scheiner, et al.
Gastroenterology|March 18, 2014
Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitisMattias Mandorfer, Simona Bota, Philipp Schwabl, et al.
AIDS (London, England)|January 14, 2016
Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver diseaseMattias Mandorfer, Philipp Schwabl, Sebastian Steiner, et al.
Wiener Klinische Wochenschrift|January 9, 2020
Portal hypertensive gastropathy is associated with iron deficiency anemiaBenedikt Simbrunner, Andrea Beer, Katharina Wöran, et al.
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.
United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.
Journal of Hepatology|November 26, 2025
A single-arm phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis CJosep M Llibre, Christoph Boesecke, Juhi Moon, et al.
Pageof 50

Showing results (241-250 of 491) with videos related to

Sort By:
Pageof 50
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Wiener Klinische Wochenschrift|July 27, 2017
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patientsDavid Chromy, Philipp Schwabl, Theresa Bucsics, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2026
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular CarcinomaTobias Meischl, Moritz Steurer, Lorenz Balcar, et al.
Digestive Diseases and Sciences|June 19, 2019
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal HypertensionGeorg Semmler, Judith Stift, Bernhard Scheiner, et al.
Gastroenterology|March 18, 2014
Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitisMattias Mandorfer, Simona Bota, Philipp Schwabl, et al.
AIDS (London, England)|January 14, 2016
Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver diseaseMattias Mandorfer, Philipp Schwabl, Sebastian Steiner, et al.
Wiener Klinische Wochenschrift|January 9, 2020
Portal hypertensive gastropathy is associated with iron deficiency anemiaBenedikt Simbrunner, Andrea Beer, Katharina Wöran, et al.
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.
United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.
Journal of Hepatology|November 26, 2025
A single-arm phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis CJosep M Llibre, Christoph Boesecke, Juhi Moon, et al.
Pageof 50